Vir Biotechnology Files 8-K on Financials
Ticker: VIR · Form: 8-K · Filed: May 7, 2025 · CIK: 1706431
| Field | Detail |
|---|---|
| Company | Vir Biotechnology, Inc. (VIR) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, financial-statements
Related Tickers: VIR
TL;DR
VIR dropped an 8-K on financials, check it for the latest numbers.
AI Summary
Vir Biotechnology, Inc. filed an 8-K on May 7, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing provides updated information regarding the company's financial status and operational performance.
Why It Matters
This filing provides investors with crucial updates on Vir Biotechnology's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Vir Biotechnology, Inc. (company) — Registrant
- May 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 1800 Owens Street, Suite 900, San Francisco, California 94158 (address) — Principal Executive Offices
- 415-906-4324 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on Vir Biotechnology, Inc.'s Results of Operations and Financial Condition, and includes Financial Statements and Exhibits.
When was this 8-K filing submitted?
The filing was submitted on May 7, 2025.
What is the principal executive office address for Vir Biotechnology, Inc.?
The principal executive office is located at 1800 Owens Street, Suite 900, San Francisco, California 94158.
What is the company's state of incorporation?
Vir Biotechnology, Inc. is incorporated in Delaware.
What is the company's telephone number?
The company's telephone number is (415) 906-4324.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Vir Biotechnology, Inc. (VIR).